Diagnocure Oncology Laboratories
  • Home
  • Previstage™ GCC
    • Overview
    • Technical Information
    • About GCC
    • How to Order
    • Test Results
  • Scientific Literature
  • Upcoming Events
  • News Announcements
  • About Diagnocure Labs
    • Introduction
    • Management and Team
    • Advisory Board
    • Licenses and Practices
    • Media
  • Contact Us
  • Careers
  • Glossary

Media

Major clinical study published:
GCC (GUCY2C), the strongest predictor of CRC recurrence

  • Press Release (PDF)
  • Fact sheet on Previstage™ GCC (for media) (PDF)
  • Abstract of JAMA article (Feb. 18, 2009)

Videos

  • The Economic Report 2009: now airing on major U.S. networks such as CNN, Fox, etc.
  • Technical animation on Previstage™ GCC

Corporate Information

  • DiagnoCure Oncology Laboratories (PDF)
  • Corporate Brochure – DiagnoCure Inc. (PDF)

Logos

  • DiagnoCure Oncology Laboratories – Color (PNG)
  • DiagnoCure Oncology Laboratories – Black & White (PNG)

Contacts

Paule De Blois, MBA
Vice President, Corporate Affairs
(418) 527-6100
communications@diagnocure.com

Email Sign Up

Subscription Form

© 2008-2010 DiagnoCure Oncology Laboratories  –  Terms of Use